| Literature DB >> 33079032 |
Benido Impouma, Maroussia Roelens, George Sie Williams, Antoine Flahault, Claudia Torres Codeço, Fleury Moussana, Bridget Farham, Esther L Hamblion, Franck Mboussou, Olivia Keiser.
Abstract
Large-scale protracted outbreaks can be prevented through early detection, notification, and rapid control. We assessed trends in timeliness of detecting and responding to outbreaks in the African Region reported to the World Health Organization during 2017-2019. We computed the median time to each outbreak milestone and assessed the rates of change over time using univariable and multivariable Cox proportional hazard regression analyses. We selected 296 outbreaks from 348 public reported health events and evaluated 184 for time to detection, 232 for time to notification, and 201 for time to end. Time to detection and end decreased over time, whereas time to notification increased. Multiple factors can account for these findings, including scaling up support to member states after the World Health Organization established its Health Emergencies Programme and support given to countries from donors and partners to strengthen their core capacities for meeting International Health Regulations.Entities:
Keywords: Integrated Disease Surveillance and Response strategy; WHO African Region; WHO Health Emergencies Programme; World Health Organization; communicable diseases; disease outbreaks; foodborne diseases; internally-displaced populations; outbreak response; refugee populations; time to control; time to detection; time to notification; vaccine-preventable diseases; vector-borne diseases; waterborne diseases
Mesh:
Year: 2020 PMID: 33079032 PMCID: PMC7588517 DOI: 10.3201/eid2611.191766
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Figure 1Exclusion criteria used to select subset of substantiated disease outbreaks reported to the WHO African Region, 2017–2019. WHO, World Health Organization.
Median time to progression for 3 outbreak milestones (detection, notification, and end) by predictor variables, WHO African Region, 2017–2019*
| Categories | Total no.† | Time to detection ( | Time to notification ( | Time to end ( | |||||
|---|---|---|---|---|---|---|---|---|---|
| No. (%)‡ | Median (IQR) | No. (%)‡ | Median (IQR) | No. (%)‡ | Median (IQR) | ||||
| Income ( | |||||||||
| Low | 156 | 107 (68.6) | 9 (2–27) | 127 (81.4) | 3 (0–8) | 109 (53.2) | 86 (37–169) | ||
| Middle and high | 140 | 77 (55.0) | 8 (2–29) |
| 105 (75.0) | 2 (0–8) |
| 92 (44.9) | 54 (24–155) |
| WHO subregion ( | |||||||||
| Eastern/Southern | 133 | 78 (58.6) | 6 (1–23) | 96 (72.2) | 3 (0–9) | 96 (46.8) | 70 (30–148) | ||
| Western | 102 | 74 (72.5) | 10 (5–28) | 88 (86.3) | 2 (0–6) | 37 (18.0) | 68 (29–158) | ||
| Central | 61 | 32 (52.5) | 16 (3–33) |
| 48 (78.7) | 2 (0–9) |
| 68 (33.2) | 136 (50–221) |
| Outbreak start date§ ( | |||||||||
| 2017 | 103 | 75 (72.8) | 14 (6–37) | 87 (84.5) | 1 (0–5) | 62 (30.2) | 131 (67–237) | ||
| 2018 | 101 | 62 (61.4) | 7 (1–27) | 83 (82.2) | 3 (0–14) | 72 (35.1) | 67 (25–144) | ||
| 2019 | 87 | 47 (54.0) | 4 (1–11) |
| 62 (71.3) | 4 (1–9) |
| 67 (32.7) | 45 (22–90) |
| No. refugees from elsewhere ( | |||||||||
| Low¶ | 199 | 129 (64.8) | 8 (3–28) | 160 (80.4) | 2 (0–8) | 133 (64.9) | 69 (25–166) | ||
| High¶ | 97 | 55 (56.7) | 8 (1–28) |
| 72 (74.2) | 3 (0–9) |
| 68 (33.2) | 84 (43–147) |
| IDP, % population ( | |||||||||
| Low¶ | 212 | 139 (65.6) | 7 (2–23) | 170 (80.2) | 3 (0–8) | 145 (70.7) | 60 (25–126) | ||
| High¶ | 84 | 45 (53.6) | 17 (2–37) |
| 62 (73.8) | 2 (0–9) |
| 56 (27.3) | 153 (65–227) |
| Disease category | |||||||||
| Food/waterborne | 74 | 47 (63.5) | 2 (0–7) | 54 (73.0) | 3 (0–6) | 60 (29.3) | 82 (24–154) | ||
| Vectorborne | 48 | 24 (50.0) | 7 (1–24) | 34 (70.8) | 3 (0–24) | 31 (15.1) | 138 (48–232) | ||
| Viral hemorrhagic fever | 56 | 41 (73.2) | 9 (6–17) | 49 (87.5) | 1 (0–4) | 37 (18.0) | 47 (28–82) | ||
| Vaccine-preventable | 85 | 49 (57.6) | 28 (8–50) | 67 (78.8) | 2 (0–15) | 52 (25.4) | 90 (52–175) | ||
| Other | 33 | 23 (69.7) | 11 (4–18) |
| 28 (84.8) | 5 (1–10) |
| 21 (10.2) | 42 (17–146) |
| Current health expenditure, % GDP ( | |||||||||
| Low¶ | 162 | 99 (61.1) | 11 (3–21) | 126 (77.8) | 2 (0–9) | 112 (54.6) | 79 (35–167) | ||
| High¶ | 134 | 85 (63.4) | 7 (2–21) |
| 106 (79.1) | 3 (0–8) |
| 89 (43.4) | 77 (27–155) |
| Population density ( | |||||||||
| Low¶ | 201 | 121 (60.2) | 11 (3–31) | 157 (78.1) | 2 (0–9) | 131 (63.9) | 76 (36–191) | ||
| High¶ | 95 | 63 (66.3) | 6 (2–18) | 75 (78.9) | 2 (0–5) | 70 (34.1) | 77 (21–130) | ||
*GDP, gross domestic product; IDP, internally displaced persons; IQR, interquartile range. †Total number based on records of total outbreaks meeting selection criteria (total for each modality = 296). ‡Numbers based on records of total outbreaks minus those with key missing dates (n [detection] = 184, n [notification] = 132, n [end] = 201 for each modality). Percentages are figured as no. in category/total number × 0.01. §Five dates missing in initial dataset. ¶Low indicates < median, high indicates > median of in-country value for variable compared with that value for all countries in the African region.
Number and frequency of disease outbreaks selected for the study on timeliness of outbreak milestones in the WHO African Region, 2017–2019
| Outbreaks | Disease category | No. (%) outbreaks |
|---|---|---|
| Cholera | Food/waterborne | 55 (18.6) |
| Measles | Vaccine-preventable | 33 (11.1) |
| Dengue fever | Vectorborne | 23 (7.8) |
| Crimean-Congo hemorrhagic fever | Viral hemorrhagic fever | 22 (7.4) |
| Poliomyelitis (circulating vaccine-derived poliovirus type2) | Vaccine-preventable | 17 (5.7) |
| Meningococcal disease | Vaccine-preventable | 16 (5.4) |
| Lassa fever | Viral hemorrhagic fever | 15 (5.1) |
| Anthrax | Other | 13 (4.4) |
| Monkeypox | Other | 12 (4.1) |
| Rift Valley fever | Viral hemorrhagic fever | 12 (4.1) |
| Yellow fever | Vaccine-preventable | 11 (3.7) |
| Malaria | Vectorborne | 10 (3.4) |
| Plague | Vectorborne | 6 (2.0) |
| Chikungunya | Vectorborne | 6 (2.0) |
| Hepatitis E | Food/waterborne | 5 (1.7) |
| Ebola virus disease | Viral hemorrhagic fever | 5 (1.7) |
| Typhoid fever | Food/waterborne | 4 (1.4) |
| Acute bloody diarrhea | Food/waterborne | 4 (1.4) |
| Pertussis | Vaccine-preventable | 3 (1.0) |
| Food--borne | Food/waterborne | 3 (1.0) |
| Listeriosis | Food/waterborne | 2 (0.7) |
| Influenza A(H1N1) | Other | 2 (0.7) |
| Rubella | Vaccine-preventable | 2 (0.7) |
| Aflatoxicosis | Food/waterborne | 2 (0.7) |
| Guinea worm disease | Other | 2 (0.7) |
| Marburg | Viral hemorrhagic fever | 2 (0.7) |
| Leishmaniasis | Vectorborne | 2 (0.7) |
| Botulism | Food/waterborne | 1 (0.3) |
| Adverse effect following immunization | Other | 1 (0.3) |
| Hepatitis A | Vaccine-preventable | 1 (0.3) |
| Rotavirus | Vaccine-preventable | 1 (0.3) |
| Zika virus disease | Vectorborne | 1 (0.3) |
| Diphtheria | Vaccine-preventable | 1 (0.3) |
| Scabies | Other | 1 (0.3) |
| Total | 296 (100.0) |
Figure 2Geographic distribution of substantiated disease outbreaks selected in study of timeliness of key outbreak milestones in the WHO African Region, 2017–2019. CCHF, Crimean-Congo hemorrhagic fever; WHO, World Health Organization. cVDPV2, circulating vaccine-derived poliovirus type 2
Results of multivariable Cox proportional hazard regression analysis of substantiated outbreaks by predictor variables, WHO African Region, 2017–2019*
| Categories | Total no.† | Time to detection ( | Time to notification ( | Time to end ( |
|---|---|---|---|---|
| Income ( | ||||
| Low | 156 | Referent | Referent | Referent |
| Middle and high | 140 | 1.01 (0.68–1.52) | 1.11 (0.71–1.73) | 1.07 (0.78–1.73) |
| Significance |
| p = 0.5147 | p = 0.6289 | p = 0.1513 |
| WHO subregion ( | ||||
| Eastern and Southern | 133 | Referent | Referent | Referent |
| Western | 102 | 1.02 (0.52–1.46) | 0.84 (0.47–1.50) | 0.94 (0.56–1.54) |
| Central | 61 | 0.81 (0.49–1.38) | 1.13 (0.65–1.97) | 0.55 (0.33–0.90) |
| Significance |
| p = 0.0427 | p = 0.6784 | p = 0.0608 |
| Outbreak start date‡ ( | ||||
| 2017 | 103 | Referent | Referent | Referent |
| 2018 | 101 | 1.68 (1.16–2.34) | 0.46 (0.31–0.70) | 1.57 (1.08–2.27) |
| 2019 | 87 | 2.59 (1.71–3.94) | 0.40 (0.25–0.64) | 0.94 (0.63–1.43) |
| Significance |
| p = 0.0000 | p = 0.0000 | p = 0.0182 |
| No. refugees from elsewhere ( | ||||
| Low‡ | 199 | Referent | Referent | Referent |
| High‡ | 97 | 1.61 (0.96–2.70) | 0.82 (0.45–1.48) | 0.80 (0.48–1.33) |
| Significance |
| p = 0.2017 | p = 0.8066 | p = 0.0236 |
| IDP, % population ( | ||||
| Low‡ | 212 | Referent | Referent | Referent |
| High‡ | 84 | 1.01 (0.64–2.70) | 1.38 (0.85–2.23) | 0.70 (0.47–1.04) |
| Significance |
| p = 0.8446 | p = 0.2843 | p = 0.0163 |
| Disease category ( | ||||
| Food/waterborne | 74 | Referent | Referent | Referent |
| Vectorborne | 48 | 0.59 (0.34–1.03) | 1.18 (0.63–2.22) | 0.89 (0.54–1.45) |
| Viral hemorrhagic fever | 56 | 0.40 (0.25–0.66) | 1.57 (0.89–2.77) | 1.20 (0.75–1.91) |
| Vaccine-preventable | 85 | 0.46 (0.29–0.73) | 1.19 (0.69–2.05) | 0.53 (0.34–0.83) |
| Other | 33 | 0.44 (0.34–1.05) | 0.91 (0.47–1.78) | 1.45 (0.85–2.46) |
| Significance |
| p = 0.0023 | p = 0.4704 | p = 0.0014 |
| Current health expenditure, % GDP ( | ||||
| Low§ | 162 | Referent | Referent | Referent |
| High§ | 134 | 1.11 (0.75–1.65) | 0.93 (0.58–1.49) | 1.02 (0.69–1.51) |
| Significance |
| p = 0.5415 | p = 0.7700 | p = 0.9354 |
| Population density ( | ||||
| Low§ | 201 | Referent | Referent | Referent |
| High§ | 95 | 1.10 (0.74–1.61) | 0.98 (0.64–1.49) | 0.96 (0.67–1.38) |
| Significance | p = 0.6555 | p = 0.9258 | p = 0.8251 |
*GDP, gross domestic product; IDP, internally displaced persons; IQR, interquartile range. †Numbers, based on records of total outbreaks meeting selection criteria (total for each modality = 296). ‡Five dates missing in initial dataset. §Low indicates < median, high indicates > median of in-country value for variable compared with that value for all countries in the African region.